Genesem제너셈
217190 · KOSDAQ · ₩217190 · 제너셈
₩8,140▲ ₩800 (10.90%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩57B | ₩69B | ₩56B | ₩60B | ₩60B |
| Cost of sales | ₩36B | ₩40B | ₩37B | ₩36B | ₩39B |
| Gross profit | ₩21B | ₩29B | ₩20B | ₩24B | ₩21B |
| Operating income | ₩1B | ₩6.5B | ₩3.6B | ₩8.5B | ₩5.6B |
| Net income | ₩947M | ₩6.1B | ₩3.6B | ₩12B | ₩5.2B |
| Net income to shareholders | ₩935M | ₩6.1B | ₩3.7B | ₩12B | ₩5.2B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | — | ₩86B | ₩78B | ₩79B | ₩68B |
| Current assets | — | ₩43B | ₩36B | ₩38B | ₩29B |
| Cash and equivalents | — | ₩20B | ₩11B | ₩10B | ₩5.2B |
| Total liabilities | — | ₩37B | ₩35B | ₩39B | ₩40B |
| Current liabilities | — | ₩30B | ₩27B | ₩27B | ₩19B |
| Borrowings | — | ₩17B | ₩15B | ₩22B | ₩21B |
| Total equity | — | ₩50B | ₩42B | ₩40B | ₩28B |
| Shareholders' equity | — | ₩50B | ₩43B | ₩40B | ₩28B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩2.1B | ₩10B | ₩3B | ₩8.5B | ₩4.4B |
| Free cash flow | −₩2.1B | ₩10B | ₩3B | ₩8.5B | ₩4.4B |
| Dividends paid | ₩658M | ₩0 | ₩658M | ₩0 | ₩0 |
Consolidated where available. Amounts in won.
Also known as: Genesem / 제너셈 / 217190 / KRX:217190
Source: KRX statistical information